By David M. Burd
Australia with its proximity to Asia over the past five years has provided valuable insight to the world of influenza, including the alleged deadly Avian (Bird) H5N1 flu strain said to originate in southeast Asia and spread by chickens and wild fowl, the H1N1 (Swine) strain promoted (needlessly) to a Worldwide Pandemic in 2009, and the constant background of Seasonal Flu that changes its strain every year being mostly "A" and "B" subtypes. During these last five years, Australian Health Officials prompted and cajoled the public to get free flu shots (also mercury-free).
Perhaps "Flu Wolf!" has been shouted too often by health officials, as flu vaccine participation (called “uptake”) remains remarkably low. This is shown by a recent survey from the Australian Institute of Health and Welfare, titled 2010 Pandemic Vaccination Survey, August 2010 (Cat. no. PHE 128) completed in February, 2010. Table 2.1 documents less than six percent (5.6%) of children under age 5 had taken the H1N1 shot in 2009, and but nine percent (9.1%) of all children under age 15. For the entire public of all ages 18.2% took the vaccine, with senior citizens aged 65+ having the highest participation at 45% (thus raising the average)..
With this background in mind, the Australian 2010 Flu Season began with an unexpected bang in late March (their winter is shifted 6 months earlier than the U.S.). Within several weeks hundreds of parents had rushed just-vaccinated children having convulsions or high fevers to hospitals, prompting Australia’s Chief Medical Officer Jim Bishop on April 23 to issue a nationwide ban of flu shots for children under five years old. This was all covered by front page stories, with ABC News Australia reporting one fatal child case associated with the vaccine jab, and latest reports cite one child still in a coma 9 months later as this is written. .
Subsequently, on July 2, 2010 the Australian Therapeutic Goods Administration (TGA) reported that 1,244 children under 5 had suffered "suspected reactions" to the trivalent influenza vaccine (TIV) up to June 4th. The report paragraph titled Adverse Events Following Immunizations (AEFs) reported to TGA is important to quote:
"There are currently four 2010 trivalent seasonal influenza vaccines approved for use in Australia, three of which have paediatric indications. They are FLUVAX/FLUVAX JR (sponsor CSL), INFLUVAC (Solvay/Abbott) and VAXIGRIP (Sanofi-Pasteur). [A fourth brand, INTANZA (Sanofi-Pasteur), is only approved for use in adults and is not included in the National Immunisation Program (NIP). As at 4 June 2010 the TGA had received a total of 1,729* AEFI reports concerning 2010 TIV (*Author's note: 1,244 of these reports were for children under 5). The summary data are presented in Table 1, listed by vaccine type. It is important to note that these data reflect all cases reported to the TGA as suspected reactions o influenza vaccination, prior to detailed case review. It is therefore likely that these numbers include errors and duplicates and may change as further information is received by the TGA."
An investigation centered on batches of flu vaccines from specified manufacturers, and also great effort was instituted for manufacture and supplying new vaccine batches deemed safe. On July 30, over four months after the initial vaccine shots' dire reactions, officials announced that children could once again get their shots.
It would strain common sense to think many parents took their children, 4 months into an extremely mild Australian flu season (as morbidity data shows) and after the carnage from March to June, for the new flu vaccine jabs. There is no data on uptake participation for the remaining flu season, but there is the final Australian Health and Ageing Report Influenza Report of 30 October- 5 November 2010 (#44/10) citing both the adult and pediatric flu hospitalizations and any mortality (subsequent the initial disaster of March to June). These results are remarkable.
For the Flu Season months that followed the March – June disaster, a total of 35 children with flu symptoms were admitted for hospital care with 5 of these further taken to intensive care units; and all were eventually discharged - there was zero mortality.
As for adults (everybody over age 15), there were 36 flu-associated deaths, with 22 of these attributed to specific H1N1 association and the rest to other flu strains. Notably, 75% of these H1N1 deaths were documented to have severe preexisting illnesses. Australia's population is 23 million, so their flu-associated mortality rate comes to 1.56 per million.
For many years, Health Officials represented by the U. S. CDC have been broadcasting grossly distorted annual mortality caused by influenza. The elaborate charts on the CDC flu website compile numbers of “influenza like illness” (called ILI) that encompasses a vast array of pneumonias and other respiratory afflictions such as respiratory syncytial virus (RSV). The public is led to believe the constant hype citing 35,000 annual Flu deaths but these are really “ILI” totals. In reality, actual annual U.S. “flu-associated” deaths are about 1,200. With a U.S. population of 310 million, this comes to a mortality rate of 3.87 per million, 2 ½ times that of Australia.
For years, and going into January, 2011, Americans are incessantly urged to get flu shots, the CDC taking the incredible stance that 25 micrograms of mercury preservative in batch shots injected into pregnant women and 6 month old infants poses no risks. In light of Australia's example of minimal flu morbidity and mortality in tandem with vaccine refusal, it behooves American parents to think for themselves and reject both flu shots and CDC's deadly dogma.
David Burd began his career as the first generation of "rocket scientists," from Northwestern University with a degree in Mechanical Engineering and Astronautical Sciences, with mankind soon bound for the moon. His most recent work includes fifteen years consulting in patent related surgical application of energy, and writing on contentious issues, springing from being an adversarial patent examiner (“show me why it works”) at the US Patent Office in the Surgery Arts.